Literature DB >> 9761505

Diurnal blood pressure variation and albuminuria in normotensive patients with insulin-dependent diabetes mellitus.

P Vörös1, Z Lengyel, V Nagy, C Németh, L Rosivall, L Kammerer.   

Abstract

BACKGROUND: Abnormalities of the systemic blood pressure are closely associated with the development of diabetic nephropathy. Our aim was to examine the relationship between diurnal blood pressure pattern and albuminuria in insulin-dependent normotensive diabetic patients before the development of overt nephropathy.
METHODS: Urinary albumin excretion rates were determined by radioimmunoassay, and 24-h ambulatory blood pressure monitoring was performed. Means and diurnal index was calculated for systolic, diastolic and mean arterial blood pressure, for day-time, night-time, and the whole day. The results of the normoalbuminuric (n = 39) and microalbuminuric (n = 29) groups are compared, and correlation of the blood pressure parameters with albuminuria is analysed.
RESULTS: Twenty-four hours and night-time mean blood pressures were significantly higher, diurnal indices characterizing the night-time blood pressure drop were smaller in the microalbuminuric group. With multiple regression analysis a significant positive correlation was found between albumin excretion rates and 24-h mean systolic blood pressure and a significant negative correlation between albumin excretion rates and the diurnal index of mean arterial pressure (r2= 0.40, P<0.0001). In the normoalbuminuric group 1 (2.6%) patient, in the microalbuminuric group 7 (24.1%/) were 'non-dippers'.
CONCLUSION: We conclude that in normotensive insulin-dependent diabetic patients the night-time decrease of blood pressure is smaller if microalbuminuria is present. Higher nocturnal blood pressure load is associated with the increase of albuminuria, even before the onset of overt diabetic nephropathy or hypertension.

Entities:  

Mesh:

Year:  1998        PMID: 9761505     DOI: 10.1093/ndt/13.9.2257

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

Review 1.  Circadian rhythm of blood pressure in renal disease.

Authors:  M Schömig; V Schwenger; E Ritz
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 2.  Chronotherapy for Hypertension.

Authors:  N P Bowles; S S Thosar; M X Herzig; S A Shea
Journal:  Curr Hypertens Rep       Date:  2018-09-28       Impact factor: 5.369

3.  Alterations of blood pressure in type 1 diabetic children and adolescents.

Authors:  Sukran Darcan; Damla Goksen; Sevgi Mir; Erkin Serdaroglu; Muammer Buyukinan; Mahmut Coker; Afig Berdeli; Timur Köse; Alphan Cura
Journal:  Pediatr Nephrol       Date:  2006-03-28       Impact factor: 3.714

Review 4.  Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients.

Authors:  Donn Hogan; Empar Lurbe; M Reza Salabat; Josep Redon; Daniel Batlle
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 5.  Nocturnal hypertension: will control of nighttime blood pressure prevent progression of diabetic renal disease?

Authors:  K M Moorthi; Donn Hogan; Empar Lurbe; Josep Redon; Daniel Batlle
Journal:  Curr Hypertens Rep       Date:  2004-10       Impact factor: 5.369

6.  Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study.

Authors:  F Giorgino; L Laviola; P Cavallo Perin; B Solnica; J Fuller; N Chaturvedi
Journal:  Diabetologia       Date:  2004-05-29       Impact factor: 10.122

Review 7.  Circadian regulation of renal function.

Authors:  Jermaine G Johnston; David M Pollock
Journal:  Free Radic Biol Med       Date:  2018-01-31       Impact factor: 7.376

8.  Pitfalls in the measurement of the nocturnal blood pressure dip in adolescents with type 1 diabetes.

Authors:  Angela Delaney; Margaret Pellizzari; Phyllis W Speiser; Graeme R Frank
Journal:  Diabetes Care       Date:  2008-11-04       Impact factor: 17.152

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.